Serum alpha 1-acid glycoprotein and the binding of drugs in obesity.
Although clinically relevant, drug-protein interactions in the morbidly obese population have not been studied thoroughly. The objective of this study was to evaluate serum chemistry profiles and the degree of serum protein binding of propranolol, diazepam and phenytoin in the serum of four female, morbidly obese (greater than 190% of ideal body weight) and eight control female subjects. Serum triglyceride concentrations were higher and high-density lipoproteins were lower in the obese subjects than in the control group. Serum albumin and total protein concentrations in the obese were not different from controls. Unexpectedly, alpha 1-acid glycoprotein concentrations were doubled in the obese subjects (mean obese value 121 mg/100 ml vs 62.9 mg/100 ml for the control subjects). Obese subjects had a mean fraction unbound (fu) for propranolol of 0.086, which was significantly different from the controls (fu = 0.123). The binding of diazepam was decreased slightly in the obese subjects. The binding of phenytoin was similar in both groups. The altered serum chemistry of obesity may play a significant role in the drug management of the obese patient by altering drug-protein interactions.
D000328:Adult; D001798:Blood Proteins / Q000378:metabolism*; D003975:Diazepam / Q000378:metabolism; D005260:Female; D006801:Humans; D009765:Obesity / Q000378:metabolism*; D009961:Orosomucoid / Q000032:analysis*; D011433:Propranolol / Q000378:metabolism; D011485:Protein Binding
D001798:Blood Proteins; D009961:Orosomucoid; D011433:Propranolol; D003975:Diazepam